tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Theriva Biologics Presents Promising Phase 2b Trial Data
PremiumCompany AnnouncementsTheriva Biologics Presents Promising Phase 2b Trial Data
2M ago
Theriva Biologics Secures $4M Through Warrant Agreement
Premium
Company Announcements
Theriva Biologics Secures $4M Through Warrant Agreement
2M ago
Theriva Biologics announces warrant inducement transaction for $4M in proceeds
Premium
The Fly
Theriva Biologics announces warrant inducement transaction for $4M in proceeds
2M ago
Theriva Biologics Approves Key Proposals at Annual Meeting
PremiumCompany AnnouncementsTheriva Biologics Approves Key Proposals at Annual Meeting
4M ago
Theriva Biologics Faces Financial Risks Amid Shifting Trade Policies and Tariffs
Premium
Company Announcements
Theriva Biologics Faces Financial Risks Amid Shifting Trade Policies and Tariffs
5M ago
Theriva Biologics Reports Promising Trial Results and Financials
Premium
Company Announcements
Theriva Biologics Reports Promising Trial Results and Financials
5M ago
Theriva Biologics Presents Promising VCN-01 Study Results
PremiumCompany AnnouncementsTheriva Biologics Presents Promising VCN-01 Study Results
7M ago
Theriva Biologics announces presentation of data from VCN-01 Phase 1 trial
Premium
The Fly
Theriva Biologics announces presentation of data from VCN-01 Phase 1 trial
7M ago
Theriva Biologics reports Q1 EPS ($1.55) vs ($7.53) last year
Premium
The Fly
Theriva Biologics reports Q1 EPS ($1.55) vs ($7.53) last year
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100